Biocon Limited has partnered with Ministry of Skill Development and Entrepreneurship (MSDE) to hire freshers as apprentices under National Apprenticeship Promotion Scheme (NAPS). Selected candidates will receive extensive on the job training for 6 to 12 months, which may be followed by full time employment opportunity in Bengaluru based on available vacancies at the time.
Candidates interested in an apprenticeship opportunity can walk in for the selection process, along with their documents.
1 Production Machine Operators - Active Pharmaceutical Ingredient (API) / Bulk Drug
Qualifications : Diploma Chemical engg. / BSc. Chemistry/MSc. Chemistry (2023 & 2024 batch freshers only)
2 Assistant Maintenance (Pharma, Biologics and Medical Device Facility) Utility
Qualifications : Diploma/graduates in Mechanical/Electrical/Instrumentation streams (2023 & 2024 batch freshers only).
Walk-In-Interview Date : Sunday, 1st September 2024
Time : 9 AM - 12 PM
Venue : Sahyadri Degree College, Tekal Road, Kolar 563101
Important:
1. Only 2023 and 2024 freshly passed out candidates are eligible for selection.
2. Candidate must carry their updated resume and marksheets.
A global leader As we search for cutting-edge ways to improve patient outcomes now in order to create a brighter future, we continue to use the pioneering spirit that paved the way for biotechnology in India. This spurs us to continuously investigate new methods for treating cancer, diabetes, and autoimmune diseases. Through our pharmaceuticals, millions of patients are given access to life-saving care and relief in more than 120 countries, and our research and development is focused on prevention, alleviation, and treatment. Our aim is to attain health parity. With the aid of state-of-the-art therapeutic platforms, our 13,500+ employees blend compassion, science, and creativity to solve problems in healthcare. Our four global businesses are biologics that are novel, biosimilars, research services, and generics.
They are indicative of Biocon's risk-aware approach, which is bolstered by adaptable network connections, a robust pipeline, and a timely "developing markets" emphasis. We have leveraged India's value advantage of unparalleled scientific competence and cost-competitive manufacturing to achieve size, speed, and quality. By enabling more patient access to pharmaceuticals globally, we want to create health equity. Our goal is to provide an affordable specialist pharmaceutical portfolio to all individuals, regardless of location. We are still investing in the development of novel therapies for cancer, diabetes, and immunology. Our scale economies and global reach are expanding.